ISSN 3105-6741(Print)
ISSN 3105-675X(Online)
往期阅览
版权信息

ISSN 3105-6741(Print)
ISSN 3105-675X(Online)
CODEN:LYYAA3
(国际标准连续出版物标识符·全球唯一标识符)
分配机构:美国化学文摘社(CAS)

编委会
主编

田明哲
同行评议专家

副主编
彭思妍  贺  颖  吕大传
曹  婷  文红琴  姜雨欣
曾浩宇  赖  萌  丁  妍
(以上排名不分先后顺序)
编委

编委会助理
施子辰
期刊主页
在线投稿
申请编委/副主编/同行评议专家
索引/检索/存档
DOI
EuroPub
欧洲学术出版中心数据库(英国)

Sci Online
研究者索引

欧亚科学期刊索引(ESJI)
武汉办事处
主任 库盛娟
电话 +86 027-8860 7188
邮箱 gjqk@qikan999.com
微信 qikan7188
地址 武汉市武昌东湖路181号
邮编 430077
Editing and Publishing
Macau Sino-Foreign Medical Publishing Limited(MSFMP)
Address
7th Floor,D, No.19,Palawak
Lane, Macau
Telephone
+853 6881 9699
Email
QuestPress@hotmail.com
Web site
http://lcyyyj.scionline2025.com

  首页 -> 往期阅览-> 2025年
《临床用药研究》( ISSN3105-6741、EISSN3105-675X ) 发布者:Quest Press 发布日期:2026/1/11
10.12479/questpress-lcyyyj.20250212 Open Access 下载0 浏览29

 

肺结核患者不良治疗结局的危险因素分析

张登莲
云南省昭通市巧家县人民医院,云南昭通,654600
摘要:目的:探讨影响肺结核患者不良治疗结局的主要危险因素,为提高治疗效果、改善患者预后提供依据。方法:回顾性分析本院2023年10月—2024年10月期间收治的54例肺结核患者,根据治疗结局分为治疗良好组(n=32)与不良结局组(n=22)。不良结局包括治疗失败、复发、中断治疗及病情进展等。收集患者的人口学特征、吸烟饮酒史、体重指数(BMI)、病程、合并症、肺部病灶范围、有无空洞形成、用药依从性及不良反应等信息,采用Logistic回归模型分析影响治疗结局的独立危险因素。结果:与治疗良好组相比,不良结局组患者更常见男性、有吸烟史、合并其他慢性疾病、BMI水平偏低、肺部空洞形成、肺叶病灶数≥3个以及治疗依从性差等情况。Logistic回归分析显示,吸烟史、合并症、低BMI、空洞形成和肺野病灶多(≥3个)为不良治疗结局的独立危险因素(P<0.05),而治疗依从性良好为保护因素(P<0.05)。结论:吸烟、体形消瘦、合并症、病灶范围广和空洞形成是肺结核不良治疗结局的高危因素,规律抗结核治疗可有效改善预后,临床应针对高危个体加强干预和随访管理。
关健词:肺结核;治疗结局;影响因素
Analysis of Risk Factors for Adverse treatment outcomes in patients with Pulmonary tuberculosis
Denglian Zhang
Qiaojia County People's Hospital, Zhaotong City, Yunnan Province, Yunnan Zhaotong, 654600
Abstract:Objective:To explore the main risk factors influencing adverse treatment outcomes in patients with pulmonary tuberculosis, and to provide a basis for improving treatment effects and prognosis of patients. Methods: A retrospective analysis was conducted on 54 patients with pulmonary tuberculosis admitted to our hospital from October 2023 to October 2024. According to the treatment outcomes, they were divided into the good treatment group(n=32)and the poor outcome group(n=22). Adverse outcomes include treatment failure, recurrence, treatment discontinuation and disease progression, etc. The demographic characteristics, smoking and drinking history, body mass index(BMI), disease duration, comorbidities, range of pulmonary lesions, presence or absence of cavity formation, medication compliance and adverse reactions of the patients were collected. Logistic regression model was used to analyze the independent risk factors affecting the treatment outcome. Results: Compared with the well-treated group, patients in the adverse outcome group were more likely to be male, have a history of smoking, have other chronic diseases, have a lower BMI level, have pulmonary cavity formation, have ≥3 lung field lesions, and have poor treatment compliance. Logistic regression analysis showed that smoking history, comorbidities, low BMI, cavity formation and multiple lung field lesions(≥3)were independent risk factors for adverse treatment outcomes(P < 0.05), while good treatment compliance was a protective factor(P < 0.05).
Keywords : Tuberculosis Treatment outcome;Influencing factors

参考文献
[1]张虹,郑祎,田敏,等.嘉兴市南湖区2017—2022年肺结核流行特征分析[J].中国乡村医药,2025,32(11):76-78.
[2]陈良玉,林霏申,郭晶,等.初治肺结核550例的中断治疗率及其相关因素分析[J].安徽医药,2025,29(06):1213-1217.
[3]晏中梅.西安市碑林区肺结核患者的流行病学特征及预防控制措施研究[J].基层医学论坛,2025,29(15):149-152.
[4]薛玉,雷轩,周琨,等.急诊重症肺结核患者死亡风险分析[J].中国医刊,2025,60(06):675-678.
[5]牛亚平.MDT式延续护理干预对耐多药肺结核患者治疗依从性及ESCA评分的影响[J].黑龙江中医药,2021,50(03):334-335.
[6]曾亚文,周亮,周海燕,等.跨理论模型下健康宣教联合膳食营养干预对耐多药肺结核患者自我管理行为的影响[J].护理实践与研究,2025,22(04):513-521.
[7]朱义江,邓雪帅.日照市东港区2021—2023年居民肺结核流行病学特征及防范策略分析[J].中国卫生标准管理,2025,16(07):31-34.
[8]殷伟彩,徐晓曼,王东昕.影响肺结核患者服药依从性的相关危险因素[J].医学临床研究,2025,42(04):586-589.
[9]王治国,李建军,焦亚洲.初治涂阳肺结核患者预后不良的影响因素[J].中国民康医学,2024,36(15):1-5.
[10]李双良,陶艳,何蓉会,等.中青年肺结核患者不良预后影响因素的回顾性队列研究[J].公共卫生与预防医学,2024,35(02):137-140.
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
同行评审报告 / 评审意见
Peer Review Report / Peer Review Comments
利益冲突
Conflict of Interest
作者声明不存在任何利益冲突。
The author declares no conflict of interest.
版权声明
Copyright Statement
本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问: https://creativecommons.org/licenses/by/4.0/
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.
 
  Peer Review
同行评审
Editorial Services
编辑服务
Research Ethics Policy
研究伦理政策
Contributorship & Authorship
贡献者与署名
About Quest Press / Macau Sino Int. Med. Press
关于 Quest Press 与 Macau Sino Int. Med. Press
  Global Indexing
全球索引
Copyright Licensing
版权许可
Data Sharing Policy
数据共享政策
Appeal/Correction/Retraction
申诉/更正/撤回
  Online Submission
线上投稿
To the Librarian
致图书馆员
Open Access Statement
开放获取声明
Misconduct Handling Policy
处理不端行为政策
  Content Licensing
内容许可
Guidelines for Reviewers
审稿人指南
Quality Control Mechanism
质量把控机制
Academic Misconduct Screening Policy
学术不端筛查政策
  Advertising Policy
广告政策
Article Processing Charge (APC)
文章处理费
Publication Ethics Policy
出版伦理政策
Call for Editorial Board Members/Associate Editors/Peer Reviewers/Editors-in-Chief
诚邀编委、副主编、同行评审专家及主编